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ABSTRACT 
Background: In addition to being associated with all-cause mortality and cardiovascular disease 
mortality, lung function has been linked with dementia. However, existing studies typically 
provide imprecise estimates due to small numbers of outcome events and are based on 
unrepresentative samples of the general population. 
Methods: Individual participant meta-analysis of six cohort studies from the Health Survey for 
England and the Scottish Health Survey (total N=54,671). Dementia-related mortality was 
identified by mention of dementia on any part of the death certificate (mean follow-up 11.7 
years). Study-specific Cox proportional hazard models of the association between lung function 
and dementia-related death were pooled using random effect meta-analysis to produce overall 
results. 
Results: There was a dose-response association between poorer lung function and a higher risk 
of dementia-related death (age- and sex-adjusted hazard ratio compared to highest quartile of 
forced expiratory volume in the first second (FEV1), 95% confidence interval: second quartile 
1.32, 0.99-1.76; third quartile 1.78, 1.30-2.43; fourth (lowest) quartile 2.74, 1.73-4.32). There was 
no significant heterogeneity in study-specific estimates (I2=0%). Controlling for height, 
socioeconomic status, smoking, and general health attenuated but did not remove the association 
(second quartile 1.15, 0.82-1.62; third quartile 1.37, 0.96-1.94; fourth quartile 2.09, 1.17-3.71).  
Results for forced vital capacity (FVC) and peak flow were similar. 
Conclusion: In these general population samples, the relation between three measures of lung 
function and dementia death followed a dose-response gradient. Being in the bottom quartile of 
lung function was associated with a doubling of the risk. 
 
Keywords: Lung function, dementia, socioeconomic factors, meta-analysis 
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WHAT IS ALREADY KNOWN ON THIS SUBJECT? 
Dementia is increasingly being acknowledged as a condition of major public health importance. 
Furthermore there is a growing recognition that exposures across the life course contribute to 
the risk of developing manifest dementia in later life. Lung function is a putative marker for 
potentially relevant life course exposures but studies linking it with dementia are scarce. 
 
WHAT THIS STUDY ADDS 
This large, general population-based study identifies a dose-response association between poorer 
lung function and the risk of dementia death with individuals at the bottom quartile of lung 
function having a two-fold increased risk compared to those at the top quartile. Further work 
examining the mechanism underlying this association may shed light on the aetiology of 
dementia and, ultimately, guide preventative strategies. 
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INTRODUCTION 
Dementia is a major, growing public health priority affecting more than 800,000 people in the 
UK and 44 million worldwide.[1] Since there are still no disease-modifying treatments,[2] the 
focus of research has moved to prevention. However, modification of cardiovascular risk factors 
in late life does not reduce dementia risk.[3]  This may relate to the slow development of the 
neuropathological processes of dementia which can begin years, or even decades, before the 
onset of symptoms[4-6] and, as a result, many now advocate the application of the life course 
paradigm to dementia epidemiology.[7] This approach suggests that exposures throughout life 
might have a detrimental or protective effect on disease risk.[8] In the absence of studies with 
follow up encompassing entire life-spans, identifying exposures which capture experiences from 
different stages of life are important in the investigation of life course effects on disease. For 
example, height – regarded as a marker of early life illness, adversity, nutrition or psychosocial 
stress[9] – has been shown to be associated with dementia.[10] Pulmonary function is also 
affected by multiple factors throughout the life course, not merely in early life, notably smoking, 
and it has been suggested that decreased lung function is linked to both cardiovascular disease[11 
12] and cognitive decline,[13-19], as well as to overall mortality.[12 20 21] However, studies 
linking lung function and dementia are scarce[22-27] and the largest include around ten thousand 
participants. Few of these studies targeted the general population. Therefore we add to the 
limited evidence base the first meta-analysis of individual-participant data using six large general 
population cohort studies. 
 
METHODS 
Data source 
The study sample comprised four Health Surveys for England[28] (1995-7 and 2001) and two 
Scottish Health Surveys[29] (1998 and 2003).  These are annual (HSE) or intermittent (SHS), 
representative, general population-based cross-sectional studies sampling community-dwelling 
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individuals in the UK. The majority of study members (82.2%) consented to mortality 
surveillance by linkage to the UK National Health Service death register, thus converting the 
original cross-sectional studies into prospective cohort studies. Study participants gave full 
informed consent and ethical approval was granted for all aspects of these studies by the London 
Research Ethics Council or the Local Research Ethics Councils prior to each survey year data 
collection. 
 
Measurement of lung function and covariables 
Pulmonary function was measured using a Vitalograph spirometer. The spirometer was 
calibrated at the start of each day and the temperature in the survey participant’s home entered 
prior to its use. Participants blew into the spirometer five times while standing up and the 
researcher recorded whether these were technically satisfactory blows. The highest value for 
forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and peak flow 
(PF) was recorded. 
 
Informants were visited by an interviewer, who measured height and weight – allowing 
computation of body mass index using the usual formula (weight[kg]/(height[m])2) – and 
subsequently by a nurse. Ethnicity was coded as white, black, Asian, and ‘Chinese or other’. Age 
upon leaving full-time education was recorded as <15, 15, 16, 17, 18, >18 years, ‘never went to 
school’, and ‘still in full-time education’. Information on occupational social class was collected 
during the interview and coded according to the Registrar General classification (professional, 
intermediate, skilled non-manual, skilled manual, part-skilled, and unskilled), a standard approach 
in the UK. Smoking status was classified as never a regular smoker, ex-smoker, and smoker with 
daily consumption recorded. Alcohol consumption was recorded as frequency of drinking. 
During the interview, participants were asked to rate their health on a five-point scale (very 
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good/good/fair/bad/very bad) and asked whether or not they suffered from a long-standing 
illness.  
 
Mortality data 
Study participants were linked to mortality data until the first quarter 2011 and all causes 
recorded on death certificates (up to ten) were obtained in addition to date of death. Dementia 
was identified from death certification according to ICD-9 codes 290.0-290.4, 294.9, 331.0-331.2, 
and 331.9 and ICD-10 codes F00, F01, F03, F09, G30, and G31. Preliminary analyses suggested 
that using dementia as underlying cause of death gave the same results as using any mention of 
dementia but, due to fewer deaths, resulted in lower statistical power (Supplementary Table 1). 
Therefore, any mention of dementia in any part of the death certificate was used as the outcome 
of interest, a standard approach in dementia epidemiology since people with dementia often die 
of other conditions.[30-33] 
 
Statistical analysis 
After ascertaining that the proportional hazards assumption had not been violated we used Cox 
proportional hazards models[34] to compute study-specific effect estimates with accompanying 
standard errors for the association between pulmonary function and dementia-related death. We 
then pooled these study-specific estimates in random effects meta-analyses. We report hazard 
ratios (HR) with accompanying 95% confidence intervals (95% CI) for four categories of each 
marker of lung function in relation to dementia-related death. Lung function categories were 
defined created by choosing pulmonary function test cut-offs which provided an approximately 
equal number of dementia deaths in each category. Since preliminary results suggested a linear 
relationship between lung function and dementia death, we also report hazard ratios per standard 
deviation (SD) disadvantage (decrease) in pulmonary function. Calendar time (months) was the 
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underlying time scale; for participants who did not die from dementia, data were censored at the 
linkage date.  
 
There was no effect modification by gender, so data for men and women were pooled and (age- 
and) sex-adjusted. Models were then additionally adjusted for a series of covariates: height, 
ethnicity, occupational social class, educational attainment, smoking, alcohol consumption, body 
mass index, self-rated general health, and longstanding illness. We then combined all these 
variables in a multivariable model. We compared the effects of controlling for different 
confounding and mediating variables on the magnitude of the association by examining the 
change in size of hazard ratio rather than a change in significance level.  
 
We computed models examining the association between lung function and all-cause mortality 
for comparison with the dementia-related death models. We also carried out a number of 
sensitivity and subgroup analyses. We repeated the multivariable model restricting the sample to 
never-smokers. We also examined the effect on the multivariable model of excluding deaths 
occurring in the first five years of follow up to investigate the possibility that individuals with 
undiagnosed dementia might have found it more difficult to comply with pulmonary function 
testing. Individuals with data missing for one or more variable and those with no missing data 
were compared using Student’s t-test for continuous variables and 2 tests for categorical 
variables. We then produced five multiply imputed datasets in SPSS version 21 and repeated the 
multivariable model using these data. All other analyses were conducted using R version 2.15.2. 
The reporting of our analyses conforms to the STROBE statement.[35] 
 
RESULTS 
Figure 1 shows the derivation of the sample used in these analyses. From an initial sample of 
73,859 participants, 5,774 (7.8%) did not consent to record linkage and 13,414 (18.1%) were 
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missing essential data.  This resulted in an analytic sample of 54,671 (mean [SD] age 46.8 [17.6] 
years). Supplementary Table 2 shows details of the individual cohort studies and comparisons 
between individuals who did and did not consent to mortality follow up are shown in 
Supplementary Table 3.  
 
Table 1 shows the baseline characteristics of the sample by pulmonary function. Poorer lung 
function was generally associated with a less favourable risk factor profile: shorter stature, fewer 
remaining in education after the compulsory school leaving age, a higher proportion from a 
manual occupational social class, a larger proportion of smokers, slightly higher body mass index, 
a smaller proportion rating their health as good or very good, and a larger proportion with a 
longstanding illness. Individuals with poorer lung function were less likely to drink alcohol at 
least once weekly. 
 
Of 7327 deaths during a mean (SD) follow up of 11.7 (3.7) years, 459 were dementia-related (139 
where dementia was recorded as the underlying cause of death). The relationship between the 
different lung function tests was high (correlation coefficient range 0.77-0.92, all p<0.001; 
Supplementary Table 4); we therefore report only results for FEV1 in relation to dementia death 
(Supplementary Table 5 shows the meta-analysis results for FVC and PF). Poorer FEV1 was 
associated with increased risk of dementia death in a dose-response pattern (Figure 2 and Table 
2): age- and sex-adjusted HR (95% CI) per SD decrease in FEV1 1.65 (1.42, 1.93; p<0.001; Figure 
3). Adjusting individually for height, educational attainment, occupational social class, smoking 
status and self-reported general health decreased the magnitude of this association somewhat; 
other covariates had negligible effects. Adjusting for groups of covariates (socioeconomic status, 
health behaviours, and illness) and multiple variables simultaneously further reduced the strength 
association but the association remained statistically significant (multivariable-adjusted HR per 
SD decrease in FEV1, 95% CI: 1.43; 1.18, 1.72; p<0.001). 
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Sensitivity and subgroup analyses 
We performed a series of subgroup analyses to ascertain the robustness of these associations 
(Supplementary Table 6).  First, restricting the sample to never-smokers did not alter our 
conclusions, although the reduction in sample size reduced the statistical power of the analyses, 
making the dose-response association seen in the main results slightly less clear. Second, 
excluding deaths occurring within the first five years of follow up to explore reverse causality 
(the possibility that people in the early stages of dementia were less able to perform pulmonary 
function tests effectively) did not affect the observed association. Third, accounting for missing 
data by multiple imputation also did not change our findings. Individuals with missing data for 
one or more variables were slightly younger, more likely to be female, less likely to be white 
British, more likely to have more than compulsory education, more likely to have a manual 
occupation, more likely to smoke, less likely to drink alcohol at least once weekly, had a lower 
BMI, were less likely to rate their health as good or very good, and were more likely to have a 
longstanding illness than participants with complete data for all variables (Supplementary Table 
7). Thus, individuals with missing data did not invariably have an unfavourable risk factor profile 
and the statistical significance of the differences is likely to relate, in part, to the large sample size. 
 
DISCUSSION 
We have shown a strong dose-response association between lung function and dementia-related 
death over an 11-year follow-up of six UK general population samples. Part of this association 
was accounted for by height, smoking, socioeconomic status, and self-reported general health 
but the association remained even after adjustment for these factors. Being in the bottom 
quartile of lung function was associated with a doubling of dementia-related death. 
 
Comparison with other studies 
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Our findings are in agreement with previous results from smaller-scale studies. The association 
between decreasing lung function and mortality has been well-described.[12 20 21] However, 
there are fewer prospective studies linking pulmonary function with dementia. The largest study 
followed 10,211 men from 13 cohorts (including geographically-defined and occupational 
samples) over 40 years and identified 160 cases of dementia from death certification.[23] 
Participants in the highest quartile of FVC had better survival compared to the lowest quartile 
although the linear trend was not statistically significant (multivariable-adjusted HR; 95% CI: 
0.54; 0.30, 0.98; ptrend=0.28). Another study followed 9837 people aged 47-70 over a median 14.1 
years.[24] However, there was substantial attrition from the initial representative sample 
(N=15,792). They found worse survival in the lowest quartile of FEV1 (multivariable-adjusted 
HR, 95% CI: 1.59; 0.91, 2.78; ptrend=0.03) and FVC (2.08; 1.16, 3.72; ptrend=0.006), compared to 
the highest quartile. Furthermore, the 205 dementia cases were identified from hospitalisation; 
while people with dementia are at an increased risk of hospitalisation,[30] the majority of 
diagnoses are made in the community, not everyone is admitted to hospital, and a dementia 
diagnosis is frequently missed on discharge.[36 37] Another study (N=9480) identified 2767 
incident dementia cases over four decades follow up but found no association between 
pulmonary function and dementia. [25] The Age, Gene/Environment Susceptibility-Reykjavik 
Study (N=3,665), over 23 years, found an association between mid-life pulmonary function 
(FEV1/height
2) and later dementia, diagnosed by a three-stage screening process (OR 0.68, 95% 
CI 0.55-0.84, P<0.001).[27] A study following 1291 women born in 1908, 1914, 1918, 1922 and 
1930 systematically sampled from the census for 29 years, identified 147 cases based on clinical 
assessment.[22] The authors reported an association between all three measures of lung function 
used and dementia (multivariable-adjusted HR per SD increase in pulmonary function; 95% CI: 
peak flow 0.77; 0.65, 0.91; FVC 0.71; 0.57, 0.92; FEV1 0.75; 0.59, 0.95). Only one of these studies 
included men and women and only one was truly representative of the general population,[25] 
the other having been subject to substantial attrition.[24]  
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Our findings are also in agreement with studies examining the relationship between pulmonary 
function and cognition, which is an aspect of dementia. The largest followed 3,036 Japanese-
American men in Hawaii for at least 23 years and measured their cognition at the end of that 
time using the Cognitive Abilities Screening Instrument: baseline FEV1 was a predictor of 
cognitive score in a linear regression.[18] Higher FEV1 aged 43 in 1,778 men and women from 
the British 1946 birth cohort was associated with better psychomotor speed at that age as well as 
slower decline over ten years in psychomotor speed but not verbal ability or memory.[13] 
Another study of 1,192 men and women living in the community using structural equation 
modelling found that, in addition to education, strenuous activity and self-efficacy predicted 
cognitive change over two years.[17] A study of 857 men from Finland, the Netherlands, and 
Italy found that baseline lung function was associated with cognitive function at least 25 years 
later only in non-carriers of APOE 4 (pinteraction<0.05).[14] A study assessing 832 male and female 
twins seven times over 19 years found changes in lung function were associated with subsequent 
cognitive change, particularly fluid cognitive abilities.[16] However, interpretation of studies 
looking at cognition at a single point in time are complicated by the fact that higher mental 
ability in childhood is associated with better lung function in later life.[15] 
 
Strengths and limitations 
The present study is by far the largest study to date of the association between lung function and 
dementia and is based on general-population samples. The use of individual participant meta-
analysis adequately accounts for clustering within cohort studies. There has been minimal 
attrition due to the record linkage methodology. 
 
However, there are a number of limitations in these data which must be acknowledged. While we 
were able to include a large number of important variables in our models, the possibility of 
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residual confounding remains. There was no information available on baseline cognitive 
function, respiratory illness or genetic factors in the HSE or SHS datasets. A further potential 
criticism is the use of dementia mortality as the outcome, though this has been used previously in 
another study of lung function and dementia.[23] The problems associated with the use of death 
certification in identifying dementia cases in observational studies include the unavoidable under-
diagnosis of dementia in the community,[38] under-recording of dementia on death 
certificates,[39] and inaccurate coding of diagnoses. However, given the non-differential loss of 
data, it is likely that death certification is an adequate outcome for observational studies 
determining relative risk. A recent study found that almost three quarters of a memory clinic 
sample diagnosed with Alzheimer disease had dementia correctly recorded on their death 
certificates.[30]  
 
Implications 
Neither the sensitivity analysis in the present study nor a detailed previous longitudinal study[16] 
found evidence to suggest that the identified association between poorer lung function and 
dementia is attributable to reverse causality, but further research is needed to confirm this given 
the association between early life cognition and later life lung function.[15] The precise 
mechanisms underlying the association between lung function and dementia remain unclear. 
Dementia may share some aetiology with cardiovascular disease[40] and this overlap in the 
conditions may explain the association, since lung function is associated with cardiovascular 
disease.[11 12] Alternatively, it may be that lung function contributes to cognitive reserve, 
protecting against cognitive decline.[15] A further possibility is that, similarly to height, lung 
function may reflect life course exposures which also modify an individual’s risk of dementia.[8 
12] We have been able to include a number of possible candidates in our models as covariates, 
including smoking and early life socioeconomic status (educational attainment, albeit based on 
recall), but these factors did not fully explain the observed association. Other hypothesised 
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mechanisms for the association between pulmonary function and dementia include 
hypoperfusion and hypoxia affecting cerebral energy metabolism and leading to oxidative 
stress.[22] The finding that lung function is only associated with cognitive change in non-carriers 
of APOE 4 may suggest a more complex relationship between pulmonary function and 
dementia.[14]  
 
Conclusions 
We have shown a dose-response association between poorer lung function and dementia-related 
death in a large, general population-based sample of men and women. Further research is 
required to characterise this association in more detail and to identify whether interventions to 
improve lung function can reduce dementia risk. 
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FIGURE 1. Derivation of sample: individual participant meta-analysis (N = 54,671) of cohort 
studies from the Health Survey for England (N=4) and the Scottish Health Survey (N=2) 
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FIGURE 2. Kaplan-Meier cumulative hazard plot by FEV1 quartile:
1 individual participant 
meta-analysis (N = 54,671) of cohort studies from the Health Survey for England (N=4) and the 
Scottish Health Survey (N=2) 
 
1 FEV1 quartiles were defined using the following cut-points to give an approximately equal 
number of dementia deaths in each category: 1.36L, 1.81L, and 2.35L 
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FIGURE 3. Forest plot of the association between decreasing lung function (age- and sex- 
adjusted hazard ratio per standard deviation decrease in FEV1) and dementia death: individual 
participant meta-analysis (N = 54,671) of cohort studies from the Health Survey for England 
(N=4) and the Scottish Health Survey (N=2) 
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TABLE 1. Baseline characteristics of study members according to pulmonary function: 
individual participant meta-analysis (N = 54,671) of cohort studies from the Health Survey for 
England (N=4) and the Scottish Health Survey (N=2) 
 
FEV1a  
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Total Nb 
N 41279 7118 3569 2705 54671 
Age [mean (SD)] 41.3 (15.0) 59.8 (13.5) 67.3 (12.1) 70.1 (13.2) 54671 
Female (%) 46.2 75.4 78.9 73.9 54671 
Height, cm [mean (SD)] 169.6 (8.9) 161.1 (7.4) 158.7 (7.7) 158.4 (9.0) 52571 
Ethnicity (% white British) 96.0 94.4 95.2 97.1 54647 
Left school ≥16 years (%) 73.5 39.6 29.4 25.9 54646 
Non-manual social class (%) 58.4 53.5 47.1 42.5 51707 
Never smoker (%) 48.5 43.2 42.1 34.5 54479 
Drinks alcohol weekly or more often (%) 70.1 54.1 46.8 46.0 53614 
Body mass index [mean (SD)] 26.2 (4.5) 27.6 (5.0) 27.8 (5.0) 26.9 (5.4) 51041 
Self-rated health good or very good (%) 82.1 65.5 53.1 41.8 54660 
Longstanding illness (%) 37.1 58.1 68.4 73.9 54663 
 
a Cut-points used were 1.36L, 1.81L, and 2.35L to give approximately equal numbers of disease events in each group 
b Total number of participants with complete data for each variable 
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TABLE 2. Hazard ratios (95% confidence intervals) for the association between FEV1
a and 
dementia-related death: individual participant meta-analysis (N = 54,671) of cohort studies from 
the Health Survey for England (N=4) and the Scottish Health Survey (N=2) 
Models 
Dementia 
deaths 
N 
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Per SD 
disadvantage 
P for trend 
Age- & sex-adjusted 
(basic model) 
459 54671 
1 
(Ref.) 
1.32 
(0.99, 1.76) 
1.78 
(1.30, 2.43) 
2.74 
(1.73, 4.32) 
1.65 
(1.42, 1.93) 
<0.001 
+ Height 413 52571 1 
1.19 
(0.88, 1.61) 
1.51 
(1.08, 2.11) 
2.19 
(1.41, 3.42) 
1.55 
(1.30, 1.84) 
<0.001 
+ Ethnicity 459 54647 1 
1.35 
(1.01, 1.81) 
1.82 
(1.33, 2.48) 
2.77 
(1.77, 4.34) 
1.68 
(1.44, 1.96) 
<0.001 
+ Socioeconomic statusb 444 51879 1 
1.31 
(0.91, 1.88) 
1.60 
(1.16, 2.19) 
2.39 
(1.40, 4.08) 
1.50 
(1.28, 1.77) 
<0.001 
+ Health behavioursc 407 49950 1 
1.26 
(0.93, 1.0) 
1.68 
(1.20, 2.35) 
2.41 
(1.63, 3.56) 
1.65 
(1.40, 1.95) 
<0.001 
+ Illnessd 459 54655 1 
1.29 
(0.95, 1.75) 
1.69 
(1.24, 2.32) 
2.93 
(1.60, 5.35) 
1.68 
(1.36, 2.07) 
<0.001 
Multivariable-adjustede 393 48025 1 
1.15 
(0.82, 1.62) 
1.37 
(0.96, 1.94) 
2.09 
(1.17, 3.71) 
1.42 
(1.18, 1.71) 
<0.001 
 
a Cut-points used for FEV1 were 1.36L, 1.81L, and 2.35L to give approximately equal numbers of disease events in each group 
b Socioeconomic status comprises occupational social class and educational attainment 
c Health behaviours include smoking, alcohol consumption, and body mass index 
d Illness comprises self-rated general health and longstanding illness 
e Model adjusted for all covariates in the table. 
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SUPPLEMENTARY TABLE 1. Hazard ratios (95% confidence intervals) for the association 
between pulmonary function in relation to dementia-related death identified by broad (any 
mention) and narrow (underlying cause) definitions: individual participant meta-analysis (N = 
54,671) of cohort studies from the Health Survey for England (N=4) and the Scottish Health 
Survey (N=2) 
 
Age- & sex-adjusted 
Models 
Dementia 
deaths 
N 
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Per SD 
disadvantage 
P for 
trend 
Any mention 459 54671 
1 
(Ref.) 
1.32 
(0.99, 1.76) 
1.78 
(1.30, 2.43) 
2.74 
(1.73, 4.32) 
1.65 
(1.42, 1.93) 
<0.001 
Underlying cause 139 54671 
1 
(Ref.) 
1.08 
(0.55, 2.14) 
1.27 
(0.66, 2.47) 
1.51 
(0.82, 2.81) 
1.37 
(1.03, 1.82) 
0.031 
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SUPPLEMENTARY TABLE 2. Characteristics of participants according to individual cohort 
studies: individual participant meta-analysis (N = 54,671) of cohort studies from the Health 
Survey for England (N=4) and the Scottish Health Survey (N=2) 
 
  Health Survey for England Scottish Health Survey  
 
  1995 1996 1997 2001 1998 2003 Overall 
Household survey response % 78 79 76 74 77 67 - 
Adults irrespective of consent status N 16055 16443 8582 15647 9040 8092 73859 
Consented to mortality linkage % 93.7 93.7 93.9 88.4 86.9 87.9 91.1 
  N 15036 15411 8060 13835 7857 7114 67313 
Participants with lung function data  
(analytic sample) 
N 12675 13291 6936 10664 6270 4835 54671 
Follow-up (years) mean 14.3 13.5 12.7 9.2 10.6 5.7 11.7 
  sd 3.4 3.1 2.6 1.5 1.9 0.9 3.7 
Deaths from any cause N 2250 2117 985 919 720 336 7327 
Dementia deaths N 146 133 67 64 31 18 459 
Age (years) mean 46.2 46.2 46.1 47.4 46.2 51.0 46.8 
  sd 18.1 18.1 17.7 17.6 15.6 17.1 17.6 
  range 16-100 16-97 16-94 16-99 16-74 16-95 16-100 
Female % 53.0 53.1 52.5 53.3 55.2 55.4 53.4 
Height (cm) mean 167.4 167.4 167.5 167.6 166.8 166.5 167.3 
 sd 9.6 9.6 9.6 9.6 9.5 9.5 9.6 
White British % 95.1 94.6 95.3 95.2 99.4 98.7 95.8 
Left school ≥16a % 61.8 63.7 63.8 68.2 61.6 63.6 63.9 
Non-manual social class % 56.8 56.1 55.9 58.1 51.8 56.5 56.2 
Never smoker % 46.7 46.2 45.7 47.7 44.6 50.1 46.7 
Drinks alcohol weekly or more often % 65.2 66.5 66.6 66.5 61.3 61.6 65.1 
Body mass index mean 26.0 26.2 26.3 26.9 26.7 27.5 26.5 
 sd 4.4 4.5 4.7 4.8 4.8 5.1 4.7 
Self-rated health good or very good % 77.2 77.2 75.7 76.0 74.9 72.2 76.1 
Longstanding illness % 42.0 42.5 44.1 45.6 44.6 45.7 43.7 
 
a Leaving school at the age of 16 years of younger approximates to completing only compulsory education, despite 
the changes in minimum school leaving age during the twentieth century 
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SUPPLEMENTARY TABLE 3. Survey participants who consented and did not consent to 
record linkage: individual participant meta-analysis (N = 54,671) of cohort studies from the 
Health Survey for England (N=4) and the Scottish Health Survey (N=2) 
 
 Consented Did not consent P 
N 67313 6546 - 
Age [mean (SD)] 46.9 (18.0) 47.9 (19.6) <0.001 
Female (%) 54.6 59.1 <0.001 
Height, cm [mean (SD)] 167.1 (9.6) 166.2 (9.8) <0.001 
Ethnicity (% non-white British) 95.6 88.1 <0.001 
Left school ≥16 years (%) 63.6 62.7 0.176 
Non-manual social class (%) 55.4 54.4 0.144 
Never smoker (%) 46.4 50.5 <0.001 
Drinks alcohol weekly or more often (%) 63.9 56.5 <0.001 
Body mass index [mean (SD)] 26.5 (4.7) 26.1 (4.7) <0.001 
Self-rated health good or very good (%) 75.0 72.6 <0.001 
Longstanding illness (%) 43.8 40.4 <0.001 
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SUPPLEMENTARY TABLE 4. Correlation matrix for the three measured lung function 
tests: individual participant meta-analysis (N = 54,671) of cohort studies from the Health Survey 
for England (N=4) and the Scottish Health Survey (N=2) 
 
 FEV1 FVC Peak flow 
FEV1 1 
0.92 
P<0.001 
0.82 
P<0.001 
FVC 
0.92 
P<0.001 
1 
0.77 
P<0.001 
Peak flow 
0.82 
P<0.001 
0.77 
P<0.001 
1 
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SUPPLEMENTARY TABLE 5. Hazard ratios (95% confidence intervals) for the association 
between pulmonary function in relation to dementia-related death: individual participant meta-
analysis (N = 54,671) of cohort studies from the Health Survey for England (N=4) and the 
Scottish Health Survey (N=2) 
 
FVC (L)    
Models 
Dementia 
deaths 
N 
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Per SD 
disadvantage 
P for 
trend 
Age- & sex-adjusted 
(basic model) 
459 54671 
1 
(Ref.) 
1.40 
(0.93, 2.11) 
1.84 
(1.28, 2.66) 
2.90 
(1.77, 4.75) 
1.52 
(1.30, 1.78) 
<0.001 
+ Height 413 52571 1 
1.26 
(0.85, 1.88) 
1.50 
(1.06, 2.13) 
2.58 
(1.48, 4.48) 
1.42 
(1.20, 1.68) 
<0.001 
+ Ethnicity 459 54647 1 
1.43 
(0.95, 2.14) 
1.87 
(1.31, 2.69) 
2.96 
(1.83, 4.79) 
1.55 
(1.33, 1.80) 
<0.001 
+ Socioeconomic status1 444 51879 1 
1.31 
(0.87, 1.96) 
1.73 
(1.14, 2.62) 
2.54 
(1.49, 4.33) 
1.45 
(1.19, 1.76) 
<0.001 
+ Health behaviours2 407 49950 1 
1.41 
(0.98, 2.02) 
1.79 
(1.26, 2.53) 
3.02 
(1.97, 4.63) 
1.57 
(1.34, 1.83) 
<0.001 
+  Illness3 459 54655 1 
1.37 
(0.89, 2.10) 
1.81 
(1.20, 2.74) 
2.98 
(1.65, 5.40) 
1.55 
(1.26, 1.90) 
<0.001 
Multivariable-adjusted4 393 48025 1 
1.24 
(0.85, 1.82) 
1.54 
(1.07, 2.24) 
2.65 
(1.48, 4.73) 
1.41 
(1.17, 1.69) 
<0.001 
PF (L/min)         
Models 
Dementia 
deaths 
N 
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Per SD 
disadvantage 
P for 
trend 
Age- & sex-adjusted 
(basic model) 
459 54671 
1 
(Ref.) 
1.53 
(1.10, 2.11) 
1.98 
(1.34, 2.91) 
3.31 
(2.32, 4.70) 
1.62 
(1.44, 1.82) 
<0.001 
+ Height 413 52571 1 
1.44 
(1.06, 1.95) 
2.00 
(1.28, 3.11) 
3.14 
(2.22, 4.45) 
1.60 
(1.41, 1.81) 
<0.001 
+ Ethnicity 459 54647 1 
1.54 
(1.12, 2.12) 
2.02 
(1.37, 2.98) 
3.37 
(2.36, 4.80) 
1.63 
(1.45, 1.83) 
<0.001 
+ Socioeconomic status1 444 51879 1 
1.43 
(0.99, 2.06) 
1.79 
(1.20, 2.66) 
2.87 
(1.94, 4.26) 
1.52 
(1.34, 1.74) 
<0.001 
+ Health behaviours2 407 49950 1 
1.47 
(1.08, 2.00) 
1.91 
(1.32, 2.7) 
3.27 
(2.31, 4.62) 
1.62 
(1.43, 1.74) 
<0.001 
+  Illness3 459 54655 1 
1.49 
(1.05, 2.10) 
1.98 
(1.28, 3.07) 
3.19 
(2.12, 4.82) 
1.62 
(1.39, 1.87) 
<0.001 
Multivariable-adjusted4 393 48025 1 
1.31 
(0.96, 1.79) 
1.66 
(1.12, 2.48) 
2.54 
(1.76, 3.66) 
1.46 
(1.27, 1.67) 
<0.001 
 
1 Socioeconomic status comprises occupational social class and educational attainment 
2 Health behaviours include smoking, alcohol consumption, and body mass index 
3 Illness comprises self-rated general health and longstanding illness 
4 Model adjusted for all covariates in the table.  
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SUPPLEMENTARY TABLE 6. Sensitivity analyses – examining the effect of: (a) excluding 
smokers; (b) excluding deaths occurring in the first 5 years of follow up and (c) accounting for 
missing data using multiple imputation: individual participant meta-analysis (N = 54,671) of 
cohort studies from the Health Survey for England (N=4) and the Scottish Health Survey (N=2) 
 
Models 
Dementia 
deaths 
N 
Q1 
(highest) 
Q2 
 
Q3 
 
Q4 
(lowest) 
Per SD 
disadvant
age 
P for 
trend 
Restricted to never-smokers (multivariable adjusted)     
FEV1 170 21928 
1 
(Ref.) 
1.34 
(0.81, 2.22) 
1.23 
(0.67, 2.25) 
1.44 
(0.74, 2.80) 
1.40 
(1.02, 1.92) 
0.039 
FVC 170 21928 
1 
(Ref.) 
1.35 
(0.80, 2.29) 
1.40 
(0.75, 2.61) 
1.70 
(0.85, 3.40) 
1.26 
(0.95, 1.68) 
0.11 
PF 170 21928 
1 
(Ref.) 
1.75 
(1.03, 2.99) 
1.62 
(0.90, 2.90) 
3.26 
(1.63, 6.51) 
1.43 
(1.14, 1.78) 
0.002 
Early deaths excluded (multivariable adjusted)      
FEV1 342 48025 
1 
(Ref.) 
1.10 
(0.78, 1.54) 
1.21 
(0.82, 1.79) 
1.55 
(1.01, 2.38) 
1.32 
(1.07, 1.64) 
0.009 
FVC 342 48025 
1 
(Ref.) 
1.20 
(0.83, 1.76) 
1.35 
(0.89, 2.04) 
1.92 
(1.20, 3.06) 
1.29 
(1.06, 1.56) 
0.012 
PF 342 48025 
1 
(Ref.) 
1.24 
(0.88, 1.75) 
1.38 
(0.94, 2.01) 
2.24 
(1.48, 3.39) 
1.37 
(1.17, 1.60) 
<0.001 
Multiple imputation (multivariable adjusted)      
FEV1 459 54671 
1 
(Ref.) 
1.17 
(0.87, 1.57) 
1.48 
(1.06, 2.06) 
2.11 
(1.38, 3.22) 
1.59 
(1.30, 1.93) 
<0.001 
FVC 459 54671 
1 
(Ref.) 
1.32 
(0.85, 2.05) 
1.59 
(1.12, 2.24) 
2.43 
(1.48, 3.99) 
1.52 
(1.25, 1.85) 
<0.001 
PF 459 54671 
1 
(Ref.) 
1.40 
(1.01, 1.94) 
1.74 
(1.16, 2.60) 
2.56 
(1.81, 3.62) 
1.58 
(1.36, 1.84) 
<0.001 
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SUPPLEMENTARY TABLE 7. Survey participants included and excluded from fully-
adjusted model: individual participant meta-analysis (N = 54,671) of cohort studies from the 
Health Survey for England (N=4) and the Scottish Health Survey (N=2) 
 
 
Complete data for all 
variables 
Missing data in ≥1 
variable 
P 
N 48025 6646 - 
Age [mean (SD)] 47.4 (16.6) 42.5 (23.2) <0.001 
Female (%) 52.7 59.0 <0.001 
Height, cm [mean (SD)] 167.3 (9.5) 166.9 (9.9) 0.010 
Ethnicity (% white British) 96.5 91.1 <0.001 
Left school ≥16 years (%) 63.4 67.6 <0.001 
Non-manual social class (%) 56.4 52.9 <0.001 
Never smoker (%) 45.7 54.5 <0.001 
Drinks alcohol weekly or more often (%) 66.3 55.3 <0.001 
Body mass index [mean (SD)] 26.6 (4.6) 24.0 (4.6) <0.001 
Self-rated health good or very good (%) 77.1 68.4 <0.001 
Longstanding illness (%) 43.3 47.1 <0.001 
 
 
 
